Japanese law firm Nishimura & Asahi advised Takeda Pharmaceutical, the largest pharmaceutical company in Asia, on its transaction to acquire all of the issued and to-be-issued ordinary share capital of Shire, a Jersey-registered and Dublin, Ireland-headquartered global specialty biopharmaceutical company.
The transaction was Japan’s biggest foreign takeover to date, and upon completion was expected to make Takeda a global top eight pharmaceutical company.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
